HCV NS3 1436-1444 mutant (HLA-A*01:01) 1444Y
€57.50 *
Prices plus VAT plus shipping costs
Delivery time 3 weeks
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
- Order number: EP11221_1
ATDALMTGY is a linear peptidic epitope (epitope ID4917) studied as part of Genome polyprotein... more
Product information "HCV NS3 1436-1444 mutant (HLA-A*01:01) 1444Y"
ATDALMTGY is a linear peptidic epitope (epitope ID4917) studied as part of Genome polyprotein from Hepatitis C virus. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays
Available downloads:
####
Sequence: | ATDALMTGY | |
Gene: | N/A | |
Delivery: | 3 weeks | |
C-Terminus: | OH | |
N-Terminus: | H | |
Purity: | 95% | |
Amount: | 1 mg | |
Counter Ion: | TFA | |
Protein: | Genome polyprotein | |
Species: | HCV | |
Allele: | HLA-A*01:01 | |
Application : | T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
Indication : | AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 |
Dokumente - Protokolle - Downloads more
Protocols and Tips
Data sheets
Viewed